BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 38394281)

  • 1. Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study.
    Sass D; Saligan L; Fitzgerald W; Berger AM; Torres I; Barb JJ; Kupzyk K; Margolis L
    Transl Psychiatry; 2021 Aug; 11(1):440. PubMed ID: 34429399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom clusters in oncology outpatients: stability and consistency across a cycle of chemotherapy.
    Harris CS; Kober K; Cooper B; Conley YP; Hammer MJ; Dhruva AA; Cartwright F; Paul S; Levine J; Miaskowski C
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e1198-e1211. PubMed ID: 36446517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel and networked symptoms in patients with breast cancer undergoing chemotherapy.
    Liang M; Zhong T; Knobf MT; Chen L; Xu M; Cheng B; Pan Y; Zhou J; Ye Z
    Eur J Oncol Nurs; 2024 Jun; 70():102566. PubMed ID: 38513452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom clusters and nutritional status in primary liver cancer patients receiving TACE.
    Zhang J; Duan H; Zhang J; Qiao H; Jiang J
    Nutr Hosp; 2024 Mar; ():. PubMed ID: 38501819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Conceptual Model of Psychoneurological Symptom Cluster Variation in Women with Breast Cancer: Bringing Nursing Research to Personalized Medicine.
    Starkweather AR; Lyon DE; Elswick RK; Montpetit AJ; Conley Y; McCain NL
    Curr Pharmacogenomics Person Med; 2013 Sep; 11(3):224-230. PubMed ID: 24497894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in Estimation of Side Effects of Chemotherapy between Physicians and Patients with Early-Stage Breast Cancer: The Use of Patient Reported Outcomes (PROs) in the Evaluation of Toxicity in Everyday Clinical Practice.
    Pavlović Mavić M; Šeparović R; Tečić Vuger A; Vazdar L
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying central symptom clusters and correlates in patients with lung cancer post-chemotherapy: A network analysis.
    Teng L; Zhou Z; Yang Y; Sun J; Dong Y; Zhu M; Wang T
    Asia Pac J Oncol Nurs; 2024 Apr; 11(4):100383. PubMed ID: 38495643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cancer Genomic Integration Model for Symptom Science (CGIMSS): A Biopsychosocial Framework.
    Grayson SC; Cummings MH; Wesmiller S; Bender C
    Biol Res Nurs; 2023 Apr; 25(2):210-219. PubMed ID: 36206160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trastuzumab-containing regimens for metastatic breast cancer.
    Balduzzi S; Mantarro S; Guarneri V; Tagliabue L; Pistotti V; Moja L; D'Amico R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006242. PubMed ID: 24919460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes and symptom clusters pattern of chemotherapy-induced toxicity in patients with early breast cancer.
    Wiranata JA; Hutajulu SH; Astari YK; Leo B; Bintoro BS; Hardianti MS; Taroeno-Hariadi KW; Kurnianda J; Purwanto I
    PLoS One; 2024; 19(2):e0298928. PubMed ID: 38394281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
    Nyrop KA; Deal AM; Shachar SS; Basch E; Reeve BB; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Reeder-Hayes KE; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
    Oncologist; 2019 Jun; 24(6):762-771. PubMed ID: 30552158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer.
    Nyrop KA; Damone EM; Deal AM; Wheeler SB; Charlot M; Reeve BB; Basch E; Shachar SS; Carey LA; Reeder-Hayes KE; Dees EC; Jolly TA; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Wood WA; Muss HB
    Breast Cancer Res Treat; 2022 Jan; 191(2):409-422. PubMed ID: 34739658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom clusters among breast cancer patients in relation to chemotherapy cycles: a longitudinal study.
    Luo R; Chen H; Liu Y; Sun H; Tang S; Chen Y
    Support Care Cancer; 2023 Sep; 31(10):573. PubMed ID: 37698687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxanes for adjuvant treatment of early breast cancer.
    Willson ML; Burke L; Ferguson T; Ghersi D; Nowak AK; Wilcken N
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD004421. PubMed ID: 31476253
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.